Dashboard
Manage Tickers

IMNNImunon, Inc.

Nasdaq imunon.com


$ 1.41 $ -0.13 (-8.61 %)    

Friday, 10-May-2024 15:53:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 443.16 $ -0.25 (-0.06 %)
DIA $ 395.16 $ -0.02 (-0.01 %)
SPY $ 521.22 $ -1.37 (-0.26 %)
TLT $ 90.44 $ 0.10 (0.11 %)
GLD $ 216.24 $ -0.94 (-0.43 %)
$ 1.38
$ 1.43
$ 1.38 x 100
$ 0.00 x 0
$ 1.41 - $ 1.43
$ 0.48 - $ 2.00
43,242
na
12.97M
$ 1.44
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-28-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-30-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-31-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-14-2021 03-31-2021 10-Q
14 03-19-2021 12-31-2020 10-K
15 11-16-2020 09-30-2020 10-Q
16 08-14-2020 06-30-2020 10-Q
17 05-15-2020 03-31-2020 10-Q
18 03-25-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-15-2019 03-31-2019 10-Q
22 03-29-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-14-2018 06-30-2018 10-Q
25 05-11-2018 03-31-2018 10-Q
26 03-27-2018 12-31-2017 10-K
27 11-14-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 05-12-2017 03-31-2017 10-Q
30 03-24-2017 12-31-2016 10-K
31 11-10-2016 09-30-2016 10-Q
32 08-15-2016 06-30-2016 10-Q
33 05-16-2016 03-31-2016 10-Q
34 03-30-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-10-2015 06-30-2015 10-Q
37 05-11-2015 03-31-2015 10-Q
38 03-12-2015 12-31-2014 10-K
39 11-10-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

imunon-reports-site-activation-for-imnn-101-phase-1-vaccine-study
IMUNON Reports Site Activation For IMNN-10...
05/13/2024 13:03:45

A second site at a tertiary center in Boston, MA is expected to be activated in the next few weeks.Proof-of-concept study for I...

imunon-q1-eps-052-beats-057-estimate
Imunon Q1 EPS $(0.52) Beats $(0.57) Estimate
05/13/2024 12:26:01

Imunon (NASDAQ:IMNN) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.57) by 8.7...

imunon-appoints-stacy-r-lindborg-as-president-and-ceo-effective-may-13-2024
IMUNON Appoints Stacy R. Lindborg As Presi...
05/08/2024 12:14:39

Assumes leadership role as Company anticipates multiple near-term clinical milestones Brings extensive leadership and experienc...

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
04/26/2024 20:31:15

imunons-ind-application-cleared-by-fda-to-begin-human-testing-of-imnn-101
IMUNON's IND Application Cleared By FDA To...
04/18/2024 12:30:58

imunon-reports-compliance-with-nasdaq-listing-requirements
IMUNON Reports Compliance With Nasdaq List...
04/11/2024 12:15:44

IMUNON, Inc. (NASDAQ:IMNN) ("IMUNON" or the "Company"), a clinical-stage drug-development company focused on de...

imunon-files-formrw-co-determined-not-to-pursue-the-public-offering-to-which-the-registration-statement-relates-the-registration-statement-has-not-been-declared-effective-by-the-sec-and-the-registrant-confirms-that-no-securities-have-been-sold-pursuant-to-the-registration-statement
Imunon Files FormRW, Co Determined Not To ...
04/10/2024 20:09:49

- SEC Filing

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
04/05/2024 12:09:50

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/02/2024 20:31:04

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/02/2024 12:07:01

hc-wainwright--co-maintains-buy-on-imunon-raises-price-target-to-13
HC Wainwright & Co. Maintains Buy on Imuno...
04/01/2024 11:18:44

HC Wainwright & Co. analyst Emily Bodnar maintains Imunon (NASDAQ:IMNN) with a Buy and raises the price target from $12 ...

imunon-q4-eps-052-beats-230-estimate
Imunon Q4 EPS $(0.52) Beats $(2.30) Estimate
03/28/2024 12:14:53

Imunon (NASDAQ:IMNN) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(2.30) by 77....

imunon-says-157m-in-cash-investments-and-accrued-interest-receivable-and-future-planned-sales-of-the-companys-remaining-13m-of-new-jersey-nols-is-expected-to-provide-cash-runway-into-q4-2024
Imunon Says $15.7M In Cash, Investments, A...
03/28/2024 12:07:30

imunon-fy2023-eps-216-beats-230-estimate
Imunon FY2023 EPS $(2.16) Beats $(2.30) Es...
03/28/2024 12:06:36

Imunon (NASDAQ:IMNN) reported quarterly losses of $(2.16) per share which beat the analyst consensus estimate of $(2.30) by 6.0...

earnings-scheduled-for-march-28-2024
Earnings Scheduled For March 28, 2024
03/28/2024 09:24:44

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per ...

preview-imunons-earnings
Preview: Imunon's Earnings
03/27/2024 17:01:43

imunon-receives-13m-from-sale-of-its-new-jersey-net-operating-losses
IMUNON Receives $1.3M From Sale Of Its New...
03/25/2024 12:38:18

hc-wainwright--co-reiterates-buy-on-imunon-maintains-12-price-target
HC Wainwright & Co. Reiterates Buy on Imun...
03/13/2024 16:41:23

HC Wainwright & Co. analyst Emily Bodnar reiterates Imunon (NASDAQ:IMNN) with a Buy and maintains $12 price target.

imunon-files-ind-application-to-begin-human-testing-of-imnn-101-expects-enrollment-in-phase-1-proof-of-concept-study-of-dna-based-vaccine-technology-to-begin-in-q2
IMUNON Files IND Application To Begin Huma...
03/13/2024 12:07:32

Company expects enrollment in Phase 1 proof-of-concept study of DNA-based vaccine technology to begin in Q2 The application fo...

imunon-president-and-ceo-corinne-le-goff-has-resigned-michael-h-tardugno-will-assume-day-to-day-leadership-until-successor-is-named
IMUNON President And CEO Corinne Le Goff H...
03/12/2024 21:03:26

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION